GJS Intelligence Information

Most consumer health brands don't sell you a product. They sell you a scientific association. They cite trials, reference mechanisms, and deploy the language of clinical research — then charge a premium for the implication that the science transfers to what's in the product. In most cases, it doesn't. The dose is wrong. The molecular form isn't the one used in the research. The mechanism belongs to a different compound. The evidence is borrowed from adjacent science and applied to something that never replicated it. GJS Intelligence is an evidence-translation intelligence practice. We audit how scientific evidence is converted into commercial health products — identifying where products are defensible, where claims outrun the evidence, and where credible commercial opportunity exists. Each report applies a structured framework built around three diagnostic questions: dose adequacy, form fidelity, and claims-evidence alignment. These questions, applied consistently across every assessed product in a defined category, produce a five-tier classification — a precise, independently derived map of which products match the science they imply, and which have borrowed credibility they cannot deliver. GJS Intelligence is built for operators, investors, founders, practitioners, ingredient suppliers, and premium brands who need to know what the evidence actually supports — before they commit capital, recommendation, or reputation to it.